These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of a bivalent vaccine against eel diseases caused by Vibrio vulnificus after its administration by four different routes. Esteve-Gassent MD, Fouz B, Amaro C. Fish Shellfish Immunol; 2004 Feb; 16(2):93-105. PubMed ID: 15123314 [Abstract] [Full Text] [Related]
3. A novel recombinant bivalent outer membrane protein of Vibrio vulnificus and Aeromonas hydrophila as a vaccine antigen of American eel (Anguilla rostrata). SongLin G, PanPan L, JianJun F, JinPing Z, Peng L, LiHua D. Fish Shellfish Immunol; 2015 Apr; 43(2):477-84. PubMed ID: 25655329 [Abstract] [Full Text] [Related]
4. Immunization of a novel bivalent outer membrane protein simultaneously resisting Aeromonas hydrophila, Edwardsiella anguillarum and Vibrio vulnificus infection in European eels (Angullia angullia). Guo S, He L, Wu L, Xiao Y, Zhai S, Yan Q. Fish Shellfish Immunol; 2020 Feb; 97():46-57. PubMed ID: 31846771 [Abstract] [Full Text] [Related]
6. Effectiveness of different vaccine formulations against vibriosis caused by Vibrio vulnificus serovar E (biotype 2) in European eels Anguilla anguilla. Collado R, Fouz B, Sanjuán E, Amaro C. Dis Aquat Organ; 2000 Nov 14; 43(2):91-101. PubMed ID: 11145457 [Abstract] [Full Text] [Related]
7. Vibrio vulnificus serovar A: an emerging pathogen in European anguilliculture. Fouz B, Larsen JL, Amaro C. J Fish Dis; 2006 May 14; 29(5):285-91. PubMed ID: 16677318 [Abstract] [Full Text] [Related]
8. Early steps in the European eel (Anguilla anguilla)-Vibrio vulnificus interaction in the gills: role of the RtxA13 toxin. Callol A, Pajuelo D, Ebbesson L, Teles M, MacKenzie S, Amaro C. Fish Shellfish Immunol; 2015 Apr 14; 43(2):502-9. PubMed ID: 25613341 [Abstract] [Full Text] [Related]
13. Role of the virulence plasmid pR99 and the metalloprotease Vvp in resistance of Vibrio vulnificus serovar E to eel innate immunity. Valiente E, Lee CT, Lamas J, Hor L, Amaro C. Fish Shellfish Immunol; 2008 Jan 14; 24(1):134-41. PubMed ID: 18053741 [Abstract] [Full Text] [Related]
14. Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus × O. aureus) with an inactivated Vibrio vulnificus vaccine. Shoemaker CA, Lafrentz BR, Klesius PH. Biologicals; 2011 Nov 14; 39(6):424-9. PubMed ID: 21982852 [Abstract] [Full Text] [Related]
15. Effectiveness of an oral enteric coated vibrio vaccine for use in salmonid fish. Wong G, Kaattari SL, Christensen JM. Immunol Invest; 1992 Jul 14; 21(4):353-64. PubMed ID: 1398784 [Abstract] [Full Text] [Related]
18. Immunological evaluation of Vibrio alginolyticus, Vibrio harveyi, Vibrio vulnificus and infectious spleen and kidney necrosis virus (ISKNV) combined-vaccine efficacy in Epinephelus coioides. Huang Z, Tang J, Li M, Fu Y, Dong C, Zhong JF, He J. Vet Immunol Immunopathol; 2012 Nov 15; 150(1-2):61-8. PubMed ID: 23010220 [Abstract] [Full Text] [Related]
19. Protective efficiency of DNA vaccination in Asian seabass (Lates calcarifer) against Vibrio anguillarum. Kumar SR, Parameswaran V, Ahmed VP, Musthaq SS, Hameed AS. Fish Shellfish Immunol; 2007 Aug 15; 23(2):316-26. PubMed ID: 17337208 [Abstract] [Full Text] [Related]